サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1405911

ピーナッツアレルギー治療の市場規模、シェア、動向分析レポート：薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント別予測、2024年～2030年

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 180 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ピーナッツアレルギー治療の市場規模、シェア、動向分析レポート：薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント別予測、2024年～2030年
出版日: 2023年12月29日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ピーナッツアレルギー治療市場の成長と動向：

Grand View Research社の最新レポートによると、ピーナッツアレルギー治療の世界市場規模は2030年までに10億1,000万米ドルに達する見込みです。

同市場は2024年から2030年にかけてCAGR 11.82％で成長すると予測されます。市場成長を後押しする主な要因としては、堅調な製品パイプライン、高い疾患罹患率、ドラッグデリバリーシステムの進歩、主要企業による戦略的イニシアティブなどが挙げられます。

市場の主要企業は、さまざまな戦略を通じてピーナッツアレルギー治療のパイプラインを強化しています。例えば、アラバックスは2022年12月にシリーズBの資金調達ラウンドを開始し、オーストラリアの著名なヘルスケア起業家であるTenmileとBrandon Capitalから2,000万米ドルの投資を獲得しました。この資金調達により、アラバックスはピーナッツにアレルギー反応を起こす人を対象としたPVX108の第II相臨床試験を開始できるようになります。このような資金調達により、研究開発プログラムの進展が期待されます。

ピーナッツ・アレルギー治療薬の承認数が増加していることも市場を刺激しています。2020年1月、米国食品医薬品局（FDA）は、Aimmune Therapeutics, Inc.が開発したPALFORZIA[Peanut（Arachis hypogaea）Allergen Powder-dnfp]を認可しました。PALFORZIAは、ピーナッツ・アレルギーの患者さんに対して承認された初めての免疫療法薬です。本剤は、ピーナッツの誤食によるアナフィラキシーを含むアレルギー反応を軽減することを目的とした経口免疫療法剤です。本薬は、アレルギーが確認された患者を対象としており、4歳から17歳の小児には初回投与量の増量が推奨されています。

2023年第1四半期現在、いくつかの有望なパイプライン製品が臨床開発中です。DBVテクノロジーズのViaskin Peanut、DupixientのCA002、サノフィとリジェネロンの共同開発であるCamallegrなどです。さらに、ADP101、VE416、INP20、CNP-201などの資産も開発中です。これらの薬剤のイントロダクションは、予測期間中の市場の成長と拡大に貢献すると予想されます。

ピーナッツアレルギー治療市場レポートハイライト

  • エピネフリンセグメントが2023年の主要市場シェアを占めました。アナフィラキシー治療の標準はエピネフリン自動注射器であり、緊急時のアレルギー管理にも不可欠です。
  • 投与経路別では、注射剤が2023年に市場を席巻しました。これは、患者中心の治療が重視されるようになり、患者にとって実用的で痛みが少なく、使いやすい注射剤の市場開拓が進められているためです。これには、ウェアラブル技術や自動注射器など、注射療法の代替デリバリーシステムの検討も含まれます。
  • 流通チャネル別では、病院薬局セグメントが2023年に最大の市場シェアを占めました。病院薬局はピーナッツアレルギーの患者へのサポートや情報提供に重点を置いています。
  • 北米は同市場において強い地域的地位を確立しています。これは、遺伝子治療、生物製剤、その他の免疫調節介入など、ピーナッツアレルギーの根本原因に対処する新たな治療戦略を現在研究している数多くの製薬会社、学術機関、研究機関が存在するためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場動向と展望
  • 市場力学
    • ピーナッツアレルギー治療の承認が増加
    • ピーナッツアレルギーの有病率の増加
    • ヘルスケア費の増加
  • 市場抑制要因分析
    • 治療費や製品にかかる費用が高い
  • 事業環境分析
    • SWOT分析;要因別（政治・法律、経済・技術）
    • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 投与経路のビジネス分析

  • ピーナッツアレルギー治療市場：投与経路の変動分析
  • 経口
  • 注射可能
  • その他

第5章 医薬品クラスのビジネス分析

  • ピーナッツアレルギー治療市場：薬剤クラスの変動分析
  • 抗ヒスタミン薬
  • エピネフリン
  • 免疫療法
  • その他

第6章 流通チャネルのビジネス分析

  • ピーナッツアレルギー治療市場：流通チャネルの変動分析
  • 病院薬局
  • 小売薬局
  • その他

第7章 地域ビジネス分析

  • 地域別ピーナッツアレルギー治療市場シェア、2023年および2030年
  • 北米
    • SWOT分析
    • 北米ピーナッツアレルギー治療市場、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • SWOT分析
    • 欧州のピーナッツアレルギー治療市場、2018年から2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • SWOT分析
    • アジア太平洋地域のピーナッツアレルギー治療市場、2018年から2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • SWOT分析
    • ラテンアメリカのピーナッツアレルギー治療市場、2018年から2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • SWOT分析
    • MEAピーナッツアレルギー治療市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参入企業の概要
  • 財務実績
  • 参入企業
    • マーケットリーダー
    • ピーナッツアレルギー治療市場シェア分析、2023年
    • 企業プロファイル
    • 戦略マッピング
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 3 Global Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 4 Global Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 5 Global Peanut Allergy Treatment Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 8 North America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 9 North America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 11 U.S. Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 12 U.S. Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 14 Canada Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 15 Canada Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Europe Peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 18 Europe peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 19 Europe peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Germany Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 21 Germany Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 22 Germany Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 UK Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 24 UK Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 25 UK Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 France Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 27 France Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 28 France Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 Italy Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 30 Italy Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 31 Italy Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Spain Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 33 Spain Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 34 Spain Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Denmark Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 36 Denmark Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Denmark Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Sweden Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 39 Sweden Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 40 Sweden Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Norway Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 42 Norway Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 43 Norway Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 China Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 49 China Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 50 China Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 Japan Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 52 Japan Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Japan Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 India Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 55 India Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 56 India Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 South Korea Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 58 South Korea Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 59 South Korea Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 Australia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 61 Australia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Australia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Thailand Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 64 Thailand Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 65 Thailand Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Latin America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 67 Latin America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 68 Latin America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 69 Latin America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Brazil Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 71 Brazil Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 72 Brazil Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Mexico Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 74 Mexico Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 75 Mexico Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 77 Argentina Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 78 Argentina Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 83 South Africa Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 84 South Africa Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 85 South Africa Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 UAE Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 90 UAE Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 91 UAE Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Peanut allergy treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Route of administration and distribution channel segment snapshot
  • Fig. 11 Drug class segment snapshot
  • Fig. 12 Competitive landscape snapshot
  • Fig. 13 Allergy diagnostics and therapeutics market value, 2023 (USD billion)
  • Fig. 14 Market dynamics
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 PESTLE analysis
  • Fig. 17 KOLs perspective
  • Fig. 18 KOLs perspective
  • Fig. 19 KOLs perspective
  • Fig. 20 Peanut allergy treatment market: Route of administration outlook and key takeaways
  • Fig. 21 Peanut allergy treatment market: Route of administration movement analysis
  • Fig. 22 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Peanut allergy treatment market: Drug class outlook and key takeaways
  • Fig. 26 Peanut allergy treatment market: Drug class movement analysis
  • Fig. 27 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Epinephrine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Immunotherapies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Peanut allergy treatment market: Distribution channel outlook and key takeaways
  • Fig. 32 Peanut allergy treatment market: Distribution channel movement analysis
  • Fig. 33 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Peanut allergy treatment market revenue, by region, 2023 & 2030 (USD Million)2023 & 2030 (USD Million)2023 & 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 North America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 U.S. peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. healthcare system: Money flow
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Drug pricing
  • Fig. 65 Asia Pacific peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Japan pharmaceutical registration
  • Fig. 69 Key country dynamics
  • Fig. 70 China peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Regulatory details: China
  • Fig. 72 Exclusivity formula
  • Fig. 73 Key country dynamics
  • Fig. 74 India peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Registration details: India
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Drug pricing: Australia
  • Fig. 79 Contribution of PBS by disease
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Korea peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Reimbursement scenario: South Korea
  • Fig. 85 Rest of Asia Pacific peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Mexico peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Regulatory framework
  • Fig. 92 Reimbursement scenario
  • Fig. 93 Key country dynamics
  • Fig. 94 Argentina peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Argentina pharmaceuticals registration details
  • Fig. 96 Argentina pharmaceuticals reimbursement details
  • Fig. 97 Rest of Latin America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Middle East and Africa peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 South Africa peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Regulatory framework: South Africa
  • Fig. 102 Regulatory framework: South Africa drug registration fees
  • Fig. 103 Key country dynamics
  • Fig. 104 Saudi Arabia peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UAE peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Kuwait peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Regulatory framework: South Africa
  • Fig. 110 Rest of MEA peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-097-6

Peanut Allergy Treatment Market Growth & Trends:

The global peanut allergy treatment market size is expected to reach USD 1.01 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 11.82% from 2024 to 2030. Some of the key factors propelling the market growth include a robust product pipeline, high disease prevalence, advancement in the drug delivery system, and strategic initiatives by key players.

Key market players are bolstering their pipeline for peanut allergy treatment through various strategies. For instance, Aravax initiated its series B funding round in December 2022, securing a USD 20 million investment from renowned Australian healthcare entrepreneurs Tenmile and Brandon Capital. This financing will enable Aravax to commence phase II clinical trials of PVX108, targeting individuals who experience allergic reactions to peanuts. Such fundings are expected to drive advancements in research and development programs.

The market is stimulated by the increasing number of product approvals for peanut allergy treatment. In January 2020, the U.S. Food and Drug Administration (FDA) granted authorization to PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp], developed by Aimmune Therapeutics, Inc. PALFORZIA is the first immunotherapy medication approved for individuals with peanut allergies. It is an oral immune therapy designed to reduce allergy responses, including anaphylaxis triggered by accidental peanut ingestion. It is intended for individuals who have a confirmed allergy, with initial dose escalation recommended for children aged four to 17.

As of the first quarter of 2023, several promising pipeline products are undergoing clinical development. These include Viaskin Peanut by DBV Technologies, CA002 by Dupixient, and Camallegr, a collaborative effort between Sanofi and Regeneron. Additionally, other assets such as ADP101, VE416, INP20, and CNP-201 are also in development. The introduction of these medications is anticipated to contribute to the growth and expansion of the market during the projected forecast period.

Peanut Allergy Treatment Market Report Highlights:

  • The epinephrine segment held the major market share in 2023. The standard of care for anaphylaxis treatment has been epinephrine auto-injectors, which are also essential in the management of allergies in emergency situations
  • By route of administration, the injectable segment dominated the market in 2023 owing to the development of injectable treatments that are practical, less painful, and easier to use for patients is being pursued in response to the growing emphasis on patient-centered care. This includes looking at alternative delivery systems for injectable therapies, such as wearable technology or auto-injectors
  • By distribution channel, the hospital pharmacy segment held the largest market share in 2023. Hospital pharmacies put more of an emphasis on offering patient support and information for people with peanut allergies
  • North America has established a strong regional position in the market. This is due to the presence of numerous pharmaceutical companies, academic institutions, and research organizations currently looking into new therapeutic strategies to address the underlying causes of peanut allergies, including gene therapy, biologics, and other immunomodulatory interventions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Drug Class and Route of Administration Snapshot
  • 2.3. Distribution Channel Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising product approvals for the treatment of peanut allergy
    • 3.4.2. Increasing prevalence of peanut allergies
    • 3.4.3. Increasing healthcare expenditure
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of the treatment and the products
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Route Of Administration Business Analysis

  • 4.1. Peanut Allergy Treatment Market: Route Of Administration Movement Analysis
  • 4.2. Oral
    • 4.2.1. Oral Market, 2018 - 2030 (USD Million)
  • 4.3. Injectable
    • 4.3.1. Injectable Market, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Drug Class Business Analysis

  • 5.1. Peanut Allergy Treatment Market: Drug Class Movement Analysis
  • 5.2. Antihistamines
    • 5.2.1. Antihistamines Market, 2018 - 2030 (USD Million)
  • 5.3. Epinephrine
    • 5.3.1. Epinephrine Market, 2018 - 2030 (USD Million)
  • 5.4. Immunotherapies
    • 5.4.1. Immunotherapies Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Distribution Channel Business Analysis

  • 6.1. Peanut Allergy Treatment Market: Distribution Channel Movement Analysis
  • 6.2. Hospital Pharmacy
    • 6.2.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Peanut Allergy Treatment Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Peanut Allergy Treatment Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. U.S. Peanut Allergy Treatment market, 2018 - 2030 (USD MILLION)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Canada Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. Germany Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. UK Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. France Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Italy Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Spain Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Denmark Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Sweden Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Reimbursement Scenario
      • 7.3.10.6. Norway Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. Japan Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. China Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. India Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. South Korea Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Australia Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.8. Thailand
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Reimbursement Scenario
      • 7.4.8.6. Thailand Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Brazil Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Mexico Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Reimbursement Scenario
      • 7.5.5.6. Argentina Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. South Africa Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. Saudi Arabia Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. UAE Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Reimbursement Scenario
      • 7.6.6.6. Kuwait Peanut Allergy Treatment market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant's overview
  • 8.2. Financial performance
  • 8.3. Participant categorization
    • 8.3.1. Market Leaders
    • 8.3.2. Peanut Allergy Treatment market Share Analysis, 2023
    • 8.3.3. Company Profiles
      • 8.3.3.1. Sanofi
      • 8.3.3.1.1. Company Overview
      • 8.3.3.1.2. Financial Performance
      • 8.3.3.1.3. Product Benchmarking
      • 8.3.3.1.4. Strategic Initiatives
      • 8.3.3.2. Aimmune Therapeutics Inc.
      • 8.3.3.2.1. Company Overview
      • 8.3.3.2.2. Financial Performance
      • 8.3.3.2.3. Product Benchmarking
      • 8.3.3.2.4. Strategic Initiatives
      • 8.3.3.3. DBV Technologies
      • 8.3.3.3.1. Company Overview
      • 8.3.3.3.2. Financial Performance
      • 8.3.3.3.3. Product Benchmarking
      • 8.3.3.3.4. Strategic Initiatives
      • 8.3.3.4. Vedanta Biosciences, Inc.
      • 8.3.3.4.1. Company Overview
      • 8.3.3.4.2. Financial Performance
      • 8.3.3.4.3. Product Benchmarking
      • 8.3.3.4.4. Strategic Initiatives
      • 8.3.3.5. Alladapt Immunotherapeutics, Inc.
      • 8.3.3.5.1. Company Overview
      • 8.3.3.5.2. Financial Performance
      • 8.3.3.5.3. Product Benchmarking
      • 8.3.3.5.4. Strategic Initiatives
      • 8.3.3.6. Regeneron Pharmaceuticals Inc.
      • 8.3.3.6.1. Company Overview
      • 8.3.3.6.2. Financial Performance
      • 8.3.3.6.3. Product Benchmarking
      • 8.3.3.6.4. Strategic Initiatives
      • 8.3.3.7. Aravax Pty Ltd
      • 8.3.3.7.1. Company Overview
      • 8.3.3.7.2. Financial Performance
      • 8.3.3.7.3. Product Benchmarking
      • 8.3.3.7.4. Strategic Initiatives
      • 8.3.3.8. Prota Therapeutics
      • 8.3.3.8.1. Company Overview
      • 8.3.3.8.2. Financial Performance
      • 8.3.3.8.3. Product Benchmarking
      • 8.3.3.8.4. Strategic Initiatives
      • 8.3.3.9. Teva Pharmaceuticals Industries Ltd.
      • 8.3.3.9.1. Company Overview
      • 8.3.3.9.2. Financial Performance
      • 8.3.3.9.3. Product Benchmarking
      • 8.3.3.9.4. Strategic Initiatives
    • 8.3.4. Strategy Mapping
      • 8.3.4.1. Expansion
      • 8.3.4.2. Acquisition
      • 8.3.4.3. Collaborations
      • 8.3.4.4. Route Of Administration/Drug Class Launch
      • 8.3.4.5. Partnerships
      • 8.3.4.6. Others